- $7.12m
- -$9.18m
- $7.30m
- 37
- 70
- 58
- 55
Annual balance sheet for Pulmatrix, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 23.4 | 31.7 | 53.8 | 35.6 | 19.2 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 7.2 | 0.084 | 0.067 | 1.3 | 0.928 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 31.4 | 32.5 | 54.8 | 38.1 | 20.8 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.9 | 1.85 | 2.41 | 0.945 | 11.5 |
Net Goodwill | |||||
Other Long Term Assets | |||||
Total Assets | 36.1 | 38.1 | 58.8 | 41 | 34 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 17.2 | 8.18 | 4.44 | 5.02 | 3.91 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 25.1 | 15 | 11.4 | 9.84 | 16 |
Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 11 | 23.1 | 47.4 | 31.1 | 18 |
Total Liabilities & Shareholders' Equity | 36.1 | 38.1 | 58.8 | 41 | 34 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |